• In November 2023, Fabric Genomics collaborated with DNAnexus and Oxford Nanopore Technologies for deployment of CLIA/CAP labs in pediatric and neonatal ICU’s. The labs will use Oxford Nanopore’s platforms to study genetic disorders in infants.

• In February 2023, Illumina, Inc. entered into a collaboration with African Centre of Excellence for Genomics of Infectious Diseases to start a training institute to increase genomic capabilities in African region

• In January 2023, SOPHiA GENETIC collaborated with the Memorial Sloan Kettering Cancer Center (MSK), a U.S. Cancer Center, to offer researchers and clinicians solutions to expand analytical and testing capabilities.

• In January 2023, Agilent Technologies, Inc. announced acquisition of Avida Biomed, a company that develops target enrichment workflows for clinical researchers utilizing NGS methods to study cancers.

• In April 2022, QIAGEN launched the Biomedical Knowledge Base in Europe, Japan, North America, and Australia to support data science applications in biotech companies

In this report, the Global Genomics Market has been segmented by Process, Technology, Deliverables, Application, and Geography.

Global Genomics Market, Segmentation by Process

The Global Genomics Market has been segmented by Process into Library Preparation and Data Analysis.

Library Preparation
The Library Preparation segment is a vital component in the genomics workflow, focusing on preparing DNA or RNA samples for sequencing. This process makes up roughly 35% of the total genomics market. Steps such as fragmentation, end repair, and adapter ligation are integral, ensuring high-quality sequencing data and optimal compatibility with next-generation sequencing platforms.

Data Analysis
The Data Analysis segment holds a dominant 65% share of the global genomics market, reflecting its crucial role in interpreting vast volumes of sequencing data. This phase employs advanced bioinformatics tools to analyze genetic variations, discover biomarkers, and support breakthroughs in fields like personalized medicine and genomic epidemiology, enhancing the overall value of genomics research.

Global Genomics Market, Segmentation by Technology

The Global Genomics Market has been segmented by Technology into Sequencing, PCR, Flow Cytometry, Microarrays and Others.

Sequencing
The Sequencing segment leads the genomics technology sector, capturing around 40% of the total market share. It plays a pivotal role in the comprehensive analysis of DNA and RNA, driving innovation in areas like personalized medicine, disease research, and evolutionary studies.

PCR (Polymerase Chain Reaction)
PCR technology accounts for approximately 25% of the genomics market, underscoring its significance in amplifying DNA sequences with high precision. This method remains essential for diagnostics, genetic testing, and the detection of infectious diseases.

Flow Cytometry
Flow cytometry holds a 15% market share in the genomics technology segment. It empowers researchers with detailed analysis of cells, enabling sorting, quantification, and characterization based on cellular properties.

Microarrays
The Microarrays segment contributes about 12% to the genomics technology market. These platforms allow for high-throughput analysis of gene expression and genetic variations, driving advancements in biomarker discovery and disease profiling.

Others
The Others category, comprising emerging technologies, holds approximately 8% of the total genomics market. This segment includes cutting-edge innovations such as CRISPR and digital PCR, expanding the scope and potential of genomic research.

Global Genomics Market, Segmentation by Deliverables

The Global Genomics Market has been segmented by Deliverables into Products and Services.

Products
The Products segment represents a significant 70% of the global genomics market. It includes a wide array of consumables, instruments, and reagents essential for genomics research, diagnostics, and therapeutic advancements. This segment continues to expand, driven by the increasing demand for reliable and high-quality genomic tools.

Services
The Services segment holds a substantial 30% share of the market, offering comprehensive solutions like data analysis, sequencing, bioinformatics, and consulting services. These offerings empower research institutions, clinical laboratories, and pharmaceutical companies to effectively utilize genomic technologies for diverse applications.

Global Genomics Market, Segmentation by Application

The Global Genomics Market has been segmented by Application into Epigenomics, Functional, Biomarker Discovery, Pathway Analysis, and Diagnostics.

Epigenomics
The Epigenomics segment comprises around 20% of the global genomics market, delving into heritable changes in gene expression that do not involve changes to the DNA sequence. It examines mechanisms like DNA methylation and histone modifications, providing critical insights into diseases such as cancer and neurological disorders.

Functional Genomics
Functional Genomics holds about 25% of the market, focusing on the analysis of gene functions and their interactions within biological systems. This segment leverages cutting-edge tools to unravel how genetic variations impact biological processes and contribute to disease development.

Biomarker Discovery
Biomarker Discovery constitutes approximately 18% of the market share, emphasizing the identification of genetic markers for disease detection, prognosis, and treatment monitoring. This segment is integral to advancing precision medicine.

Pathway Analysis
The Pathway Analysis segment accounts for roughly 15% of the genomics market, mapping complex biological pathways to enhance understanding of cellular processes. It supports drug development and aids in identifying new therapeutic targets.

Diagnostics
Diagnostics captures about 22% of the market, applying genomic insights to improve early disease detection and guide targeted therapies. This segment integrates genomics into clinical practice to enhance personalized patient care.

Global Genomics Market, Segmentation by Geography

In this report, the Global Genomics Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Genomics Market Share (%), by Geographical Region, 2024

North America
North America commands a dominant 45% share of the global genomics market, supported by advanced healthcare infrastructure, substantial research funding, and a concentration of leading industry players. This region continues to drive innovation, with increasing adoption of genomic technologies in clinical and research settings.

Europe
Europe holds approximately 25% of the genomics market, propelled by robust research investments, collaborative initiatives, and a strong focus on regulatory compliance. The region fosters safe and effective use of genomics, with a growing emphasis on personalized healthcare and diagnostics.

Asia Pacific
The Asia Pacific region accounts for around 20% of the market and is witnessing accelerated growth. Factors such as expanding biotechnology sectors, rising healthcare investments, and increasing demand for personalized medicine and advanced diagnostics fuel its expansion.

Middle East and Africa
The Middle East and Africa segment captures nearly 5% of the genomics market. While currently a smaller share, this region is gaining momentum through rising healthcare awareness, emerging genomic initiatives, and partnerships with global genomics companies.

Latin America
Latin America contributes about 5% to the genomics market, driven by enhanced research efforts, evolving healthcare systems, and the increasing adoption of cutting-edge diagnostic technologies. This region presents opportunities for growth, with rising investments in genomics research.